Intraoperative Ventricular Tachycardia Ablation During Left Ventricular Assist Device Implantation in High-Risk Heart Failure Patients

Circ Arrhythm Electrophysiol. 2022 Jun;15(6):e010660. doi: 10.1161/CIRCEP.121.010660. Epub 2022 May 26.

Authors

Sinan Tankut¹, Igor Gosev^{2

3}, Ayhan Yoruk⁴, Arwa Younis⁴, Scott McNitt², Milica Bjelic², Himabindu Vidula¹, Isaac Wu⁵, Mehmet K Aktas¹, Ilan Goldenberg², David T Huang¹

Affiliations

¹ Department of Cardiology (S.T., H.V., M.K.A., D.T.H.), University of Rochester, NY.
² Clinical Cardiovascular Research Center (I.Goldenberg, S.M., M.B., I.G.), University of Rochester, NY.
³ Department of Cardiac Surgery (I.Gosev), University of Rochester, NY.
⁴ Department of Electrophysiology, University of California San Francisco (A.Y.).
⁵ Department of Cardiac Anesthesia (I.W.), University of Rochester, NY.

PMID: 35617273
DOI: 10.1161/CIRCEP.121.010660

No abstract available

Keywords: catheter ablation; heart failure; hospitalization; mortality; tachycardia.

Publication types

Letter

MeSH terms

Catheter Ablation* / adverse effects
Heart Failure* / diagnosis
Heart Failure* / surgery
Heart-Assist Devices* / adverse effects
Humans
Tachycardia, Ventricular* / diagnosis
Tachycardia, Ventricular* / etiology
Tachycardia, Ventricular* / surgery
Treatment Outcome